Clasp Therapeutics
Cambridge
About Clasp Therapeutics
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $150.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2024)
- Website: clasptx.comhome#about-us
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/clasp-therapeutics-93123 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.